Open access peer-reviewed chapter

4(3H)-Quinazolinone Derivatives: Syntheses, Physical Properties, Chemical Reaction, and Biological Properties

Written By

Samir Y. Abbas

Submitted: 26 March 2019 Reviewed: 11 October 2019 Published: 22 January 2020

DOI: 10.5772/intechopen.90104

From the Edited Volume

Quinazolinone and Quinazoline Derivatives

Edited by Ali Gamal Al-kaf

Chapter metrics overview

1,277 Chapter Downloads

View Full Metrics

Abstract

4(3H)-Quinazolinone derivatives have considerable great interesting due to the diverse range of their biological properties. This review summarized the methods of preparation of 2-substituted-4(3H)-quinazolinone, 3-substituted-4(3H)-quinazolinone and 2,3-disubstituted-4(3H)-quinazolinone derivatives. Chemical reaction of 4(3H)-quinazolinone derivatives and the reactivity of the 2-methyl group, reactivity of the 3-amino group, electrophilic substitution, oxidation, reduction, reaction of 4(3H)-quinazolinones with metal ions, Mannich reaction, cycloaddition reaction as well as other reagents were discussed. Also, biological properties of 4(3H)-quinazolinone derivatives were given herein.

Keywords

  • 4(3H)-quinazolinones
  • quinazolines
  • syntheses
  • reaction
  • biological activity

1. Introduction

Quinazolinones are very significant heterocyclic compounds because of their potential pharmaceutical and biological activities. Quinazolinone derivatives reveal various medicinal properties such as analgesic, anti-inflammatory and anticancer activities, as well as antimicrobial activity. These heterocycles are valuable intermediates in organic synthesis. Therefore, various procedures have been developed for preparing these important compounds [1, 2, 3, 4, 5].

Advertisement

2. Syntheses of 4(3H)-quinazolinones

The syntheses of quinazolinones will be classified into the following three categories based on the substitution patterns of the ring system:

  • 2-Substituted-4(3H)-quinazolinones

  • 3-Substituted-4(3H)-quinazolinones

  • 2,3-Disubstituted-4(3H)-quinazolinones

2.1 2-Substituted-4(3H)-quinazolinones

2.1.1 Amidation and cyclization of 2-aminobenzoic acid derivatives (anthranilic acid derivatives)

The most common approach involves amidation of 2-aminobenzoic acid derivatives ( Figure 1 ). As an example, anthranilic acid derivatives 1 were coupled with the appropriate acid chloride to generate the corresponding substituted anthranilates 2 which underwent cyclization by treatment with acetic anhydride under reflux afforded the benzoxazin-4-ones 3. Treatment of the benzoxazinones 3 with ammonia solution afforded the quinazolinone derivatives 4 [6]. Benzoxazinone derivatives can be obtained by treatment of anthranilic acid derivatives with acetic anhydride [7]. Also, the condensation of anthranilic acid derivatives with the ortho esters and ammonium acetate afforded the 2-substituted-4(3H)-quinazolinone derivatives [8, 9]. 2-Carboethoxy-quinazoline-4(3H)-one has been synthesized from the reaction of anthranilamide and diethyl oxalate [10].

Figure 1.

Synthesis of 2-substituted-4(3H)-quinazolinones 4.

2.1.2 Condensation of imidates with 2-aminobenzoic acid

Reaction between imidates and anthranilic acid 1 was reported for preparation of a series of quinazoline antifolate thymidylate synthase inhibitors [11]. The condensation of 1 and imidates 5 in methanol at 80°C afforded the desired quinazolinones 6 in good yield ( Figure 2 ). The condensation reaction afforded the quinazolinones 6 in satisfactory to good yields. Connolly and Guiry extended this methodology to synthesize a series of 2-aryl- and 2-alkylquinazolinones [12].

Figure 2.

Synthesis of 2-substituted-4(3H)-quinazolinones 6.

2.1.3 Synthesis of quinazolinones from resin-bound isothioureas

A concise and efficient solid-phase synthesis of 2-amino-4(3H)-quinazolinones 9 has been reported by involving the reaction of polymer-bound isothioureas 8 with isatoic anhydride derivative 7 with good yield and purity ( Figure 3 ) [13].

Figure 3.

Synthesis of 2-amino-4(3H)-quinazolinones 9.

2.1.4 Hetero-Diels: alder synthesis of 2-substituted quinazolinones

Synthesis of 2-substituted-quinazolinones 12 was reported by the cyclisation of 1-aryl-4-dimethylamino-2-phenyl-1,3-diaza-1,3-butadienes 10 and phenyl isocyanate 11 [14]. The reaction was carried out under an atmosphere of nitrogen in toluene at reflux temperature, to furnish the desired products 12 in good yield ( Figure 4 ).

Figure 4.

Synthesis of 2-substituted-4(3H)-quinazolinones 12.

2.1.5 Reaction of nitriles with lithiated 2-aminobenz- amides

A developed procedure for the synthesis of 2-aryl- and 2-alkyl-4(3H)-quinazolinones 4 by reaction of lithium 2-(diethyl aminocarbonyl) anilide 14 with the appropriate aryl or aliphatic nitrile has been reported [15]. This route is highly efficient when aryl and hetero-aryl nitriles were used. The intermediate 14 was prepared in situ by treating 13 with LDA in THF at −30°C ( Figure 5 ).

Figure 5.

Synthesis of 2-substituted-4(3H)-quinazolinones 4.

2.1.6 Condensation of anthranilate esters with guanidine

The 2-amino-4(3H)-quinazolinone 17 has been prepared from the reaction of methyl anthranilate 15 with excess guanidine 16 in the presence of sodium ethoxide in ethanol ( Figure 6 ) [16].

Figure 6.

Synthesis of 2-amino-4(3H)-quinazolinone 17.

2.1.7 Direct condensation of aldehydes and anthranilamide and its derivatives

Condensation of anthranilamide with aryl, alkyl and hetero-aryl aldehydes in refluxing ethanol in the presence of CuCl2 generated the Schiff base intermediate 18, which, in turn, was converted into the 2-substituted quinazolinones 4 in excellent yield ( Figure 7 ). In a one-pot procedure, the aldehyde, anthranilamide and 3 equiv. of CuCl2 were heated under reflux in ethanol for 2–3 h. After purification by chromatography, the 2-substituted quinazolinones 4 were isolated in 71–88% yield [17].

Figure 7.

Synthesis of 2-substituted-4(3H)-quinazolinones 4.

2.2 3-Substituted-4(3H)-quinazolines

2.2.1 Vilsmeier reagent in quinazolinone synthesis

3-Substituted-4(3H)-quinazolinone derivatives 22 have been prepared by treating 5-substituted-2-aminobenzoic acid derivatives 1 with the Vilsmeier reagent 19 [18] to give the corresponding acid chlorides 20. When the external amine was added to the reaction mixture at low temperature, the added amine reacted with the acid chloride 20 with subsequent loss of HCl followed by cyclisation to afford the intermediate 21, which then expels a dimethyl amino group to afford the appropriately substituted quinazolinone 22 ( Figure 8 ).

Figure 8.

Synthesis of 3-substituted-4(3H)-quinazolinones 22.

2.2.2 Via benzoxazinones

The (4H)-3,1-benzoxazin-4-one 23 was reacted with amines under reflux to afford the quinazolinones 24 good yields ( Figure 9 ) [19].

Figure 9.

Synthesis of 3-substituted-4(3H)-quinazolinones 22.

2.2.3 Via metal salts as catalyst

4(3H)-Quinazolinones 22 have been synthesized in high to excellent yields through the one-pot condensation of anthranilic acid 1, trimethyl orthoformate and primary amines in the presence of 5 mol % of bismuth (III) trifluoroacetate (Bi(TFA)3) immobilized on n-butylpyridinium tetrachloroferrate ([nbp] FeCl4) as ionic liquid ( Figure 10 ) [20]. Also, the one-pot reaction was carried out in the presence of lanthanum (III) nitrate hexahydrate or p-toluenesulfonic acid [21].

Figure 10.

Synthesis of 3-substituted-4(3H)-quinazolinones 22.

2.3 2,3-Disubstituted-4(3H)-quinazolines

2.3.1 Formation of 2,3-disubstituted quinazolinones via benzoxazinone

Benzoxazinones are well-known as common intermediates in the synthesis of 2,3-disubstituted quinazolinones 24. The most common approaches to synthesize 3,2-disubstituted-4(3H)-quinazolinone derivatives involve amidation of anthralinic acid derivatives 1 and then treatment of the amidated anthranilic acid derivatives 2 with acetic anhydride to afford 3,1-benzoxazin-4-ones 3 in good yield, followed by condensation with nitrogen nucleophiles such as aromatic amines [22, 23, 24] or heterocyclic amines [25] ( Figure 11 ).

Figure 11.

Synthesis of 2,3-disubstituted quinazolinones 24.

Condensation of benzoxazinone 3 with hydrazine hydrate in n-butanol afforded 3-amino-quinazolinones 25 in good yield ( Figure 12 ) [26, 27]. Also, bis-quinazolinones 26 were prepared by condensation of two moles of benzoxazinones 3 with one mole of a diamine under reflux [28].

Figure 12.

Synthesis of 3-amino-quinazolinones 25 and bis- quinazolinones 26.

2.3.2 Formation of 2,3-disubstituted quinazolinones via amide derivatives

Xue et al. reported the optimisation of Grimmel’s conditions for generating 2,3-disubstituted-4(3H)-quinazolinones [29]. Thus, when amide derivatives 2 were heated with anilines in toluene or xylene in the presence of dehydrating agents such as phosphorous trichloride, phosphorous oxychloride or thionyl chloride, quinazolinone derivatives 24 were afforded. Benzenesulfonyl chloride was employed as coupling agent [30]. Treatment of amide derivatives 2 with hydrazine hydrate afforded 3-aminoquinazolinone derivatives 25 ( Figure 13 ).

Figure 13.

Synthesis of 3-aminoquinazolinone derivatives 25.

2.3.3 Combinatorial approach to quinazolinones

Traceless and chemoselective approach for the solid-phase synthesis of 2-arylamino-substituted quinazolinones with the possibility of manipulation at three positions has been developed by Yu et al. [31]. The nitro group at compounds 27 was subjected to reduction using tin(II) to afford the ortho-amino derivatives 28 and subsequently reacted with some aryl isothiocyanates to give thiourea derivatives 29. The thiourea derivatives 29 were subjected to react at first with 2-chloro-1-methyl pyridinium iodide (Mukaiyama’s reagent) and then reacted with the primary amines to afforded the guanidine derivatives 30. When the guanidine derivatives 30 were subjected to intramolecular cyclisation using hydrofluoric acid, the desired 2-amino-substituted quinazolines 31 were obtained in good yields ( Figure 14 ).

Figure 14.

Synthesis of 2-amino-substituted quinazolines 31.

2.3.4 Quinazolinone derivatives via palladium-catalyzed cyclocarbonylation

Cyclocarbonylation of o-iodoanilines 32 with ketenimine 33 using a palladium acetate/diphenylphosphinoferrocene catalyst was employed under a carbon monoxide pressure to afford the 2-alkyl-4(3H)-quinazolinones 34 in good to excellent yields ( Figure 15 ) [32].

Figure 15.

Synthesis of 2-alkyl-4(3H)-quinazolinones 34.

2.3.5 Chemoselective lithiation of quinazolinone derivatives

By direct lithiation of the 2-unsubstituted quinazolinone 22, it was possible to carry out a range of electrophilic substitutions [19]. Also, chemoselective lithiation of 3-(acylamino)-quinazolines 35 was obtained by using of LDA where the reaction was regioselective at position 2. The similar phenomenon was observed with the corresponding 2-methyl quinazolines [33]. Reactions of the dilithio reagents with a range of electrophiles resulted in the production of the corresponding 2-substituted-4(3H)-quinazolinone derivatives 37 ( Figure 16 ).

Figure 16.

Synthesis of 2-substituted-4(3H)-quinazolinone derivatives 37.

2.3.6 Formation of 2,3-disubstituted quinazolinones via isatoic anhydride

A more attractive and atom-efficient strategy for the preparation of 2,3-dihydroquinazolin-4(1H)-ones 38 was reported, which involved a one-pot three-component reaction of isatoic anhydride 7, aldehydes and amines ( Figure 17 ) [1, 34]. Multi-component reactions or one-pot syntheses are attractive synthetic strategies, where the diversity may be achieved and the products are formed in a single step. A new method for the synthesis of 2-substituted-3-(phenylamino)-dihydroquinazolin-4(1H)-ones was developed; isatoic anhydride, phenylhydrazine and aldehyde using bentonite as catalyst in aqueous media under ultrasonic irradiation. This procedure showed good functional group tolerance [35].

Figure 17.

Synthesis of 2,3-dihydroquinazolin-4(1H)-ones 38.

Advertisement

3. Physical properties of 4(3H)-quinazolinones

3.1 Stability and tautomeric phase

4(3H)-Quinazolinones are stable to mild acid and alkaline treatment. They can be sublimated, and their parent substances can be redistillated. Weddige [36] recognized the tautomeric properties of 4(3H)-quinazolinones which could exit in three tautomeric forms 39a, 39b and 39c ( Figure 18 ). The presence of 4-hydroxy form 39b was shown by its stability in aqueous alkali at pH 12 to give the anion. 4-Quinazolinones 39a and 39c are insoluble in alkali when a substitute is present on N1 or N3.

Figure 18.

Tautomaric properties of 4(3H)-quinazolinones 39 and 40.

3.2 IR spectra

The IR spectra of 4(3H)-quinazolinone is characterized by a strong carbonyl band 39a and 39c at 1681 cm−1 and the N▬H stretching band at 3402 cm−1 (inflection). Methyl groups in positions 2 and 3 have nearly the same effect in causing the carbonyl frequency to be lowered by 20–30 cm−1. While methyl group at positions 1 and 2 lowered the frequency by 67 cm−1, this large change was attributed to the presence of the β-double bond which is conjugated with the carbonyl group [37].

3.3 UV spectra

The apparent dissociation constants of 4(3H)-quinazolinone 39 and 2-substituted-4(3H)-quinazolinones 40 were determined ( Figure 18 ). Also, Ab initio quantum chemical calculations were performed for all possible tautomeric and protonation. The observed UV spectra revealed the number of dissociation constants. They concluded that the curves of 4(3H)-quinazolinones could be accounted for a mixture of tautomers due to the mobil hydrogen atom on N-3. The results showed a good correlation between experimentally determined pKa values and theoretically calculated energies [38].

3.4 NMR spectroscopic studies of 4(3H)-quinazolinones

The NMR assignments of compound 41 ( Figure 19 ) was based on simple 1H and 13C measurements and corroborated by 1H-1H COSY, gradient-enhanced 13C-1H HSQC and 13C-1H HMBC experiments. The 1H NMR spectrum showed the aromatic protons in the range 7.27-8.56 ppm. From the 2D spectra, the signal assignments were thus at δ values: 8.56 (H5), 7.61 (H6), 7.65 (H7) and 7.27 ppm (H8) [39].

Figure 19.

Numbering of 4(3H)-quinazolinone 41.

Advertisement

4. Chemical reaction of 4(3H)-quinazolinones

4.1 Reactivity of the 2-methyl group

4.1.1 Oxidation

The methyl group in the structure of 2-methyl-4(3H)-quinazolinones 24 has possibility for oxidation to generate further useful fictionalization at this position [22, 23, 24]. So, by using SeO2 as oxidant agent, the methyl group in 24 was converted to formyl group, and the novel 4(3H)-quinazolinone-2-carboxaldehydes 42 were furnished and subjected to further reaction to give new quinazoline derivatives having a azomethine, oxazolone, imidazolidine, pyrazolidine, pyridine, pyrimidine and variously substituted C-2. Also, series of 3-aryl-4(3H)-quinazolinone-2-carboxaldehyde thiosemicarbazones were synthesized via condensation of the 4(3H)-quinazolinone-2-carboxaldehydes 42 with the desired thiosemicarbazide derivatives ( Figure 20 ).

Figure 20.

Synthesis of 4(3H)-quinazolinone-2-carboxaldehydes 42.

4.1.2 Reaction with aldehydes

The 2-methyl group in substituted 4(3H)-quinazolinone is reactive as shown by the ease of its condensation with aldehydes to give the corresponding 2-styryl derivatives. 6-Chloro-2-methyl-quinazolin-4(3H)-one was refluxed for 12 h in glacial acetic acid with pyridine-2-carbaldehyde to give 6-chloro-2-(2-pyridin-2-yl-vinyl)-4(3H)-quinazolinone [7]. Also, a series of 3-[5-substituted phenyl-1, 3, 4-thiadiazole-2-yl]-2-styryl-4(3H)-quinazolinones 43 were synthesized by refluxing equimolar amount of 3-(1′3′4′-thiadiazolyl)-2-methyl quinazoline and aromatic aldehyde in glacial acetic acid [40] ( Figure 21 ).

Figure 21.

Synthesis of 2-styryl-4(3H)-quinazolinones 43.

4.1.3 Bromination

The methyl group in 2-methyl-3-aryl-quinazoline has been found to undergo bromination by bromine to give bromomethyl compound 44 ( Figure 22 ). Many compounds were synthesized via treatment compound 44 with potassium salts of organic compounds [40]. Other compounds were synthesized via treatment compound 47 with amine [41].

Figure 22.

Synthesis 2-bromomethyl-3-aryl-quinazolines 44.

4.1.4 Lithiation

2-Methyl-4(3H)-quinazolinone 45 underwent fold metalation with alkyl lithium to form lithio salt 46 which react with electrophilies (methyl iodide, ethyl iodide, allyl bromide, benzyl chloride, etc.) exclusively at the exocyclic carbanion site to produce quinazolinone derivatives 47 ( Figure 23 ) [42, 43, 44].

Figure 23.

Synthesis 2-substitutedmethyl-3-aryl-quinazolines 47.

4.1.5 Acylation

A series of 4(3H)-quinazolinones 48 [45] structurally related to methaqualone (2-methyl-3-o-tolyl-4(3H)-quinazolinone) were synthesized and evaluated for anticonvulsant activity. They prepared by treating 2-methyl-3-aryl-4(3H))-quinazolinone 45 with sodium hydride followed by the appropriate methyl or ethyl ester ( Figure 24 ).

Figure 24.

Synthesis 2-substitutedmethyl-3-aryl-quinazolines 48.

4.2 Reactivity of the 3-amino group

4.2.1 Synthesis of cyanoacetamide derivative synthons

The thermal fusion of 3-amino-4(3H)-quinazolinone 49 with ethyl cyanoacetate afforded cyanoacetamide derivatives 50 ( Figure 25 ). Cyanoacetamide derivatives 50 are highly reactive, polyfunctional compounds that possess both electrophilic and nucleophilic centres. Cyanoacetamide derivative 50 was widely used as an active synthon for the syntheses of many open-chain systems and polysubstituted heterocyclic compounds. The chemical properties of cyanoacetamide derivative 50 have been used to design various heterocyclic moieties with different ring sizes [26].

Figure 25.

Synthesis of cyanoacetamide derivatives 50.

4.2.2 Condensation with aldehydes

A series of Schiff’s bases 51 were prepared essentially by the usual condensation reaction between the 3-amino-quinazolinone derivative 25 and the aldehydes ( Figure 26 ). On the other hand, when two moles of compound 25 were treated with one mole of terephthaldehyde in ethanol under reflux, the polycyclic compound was obtained as bis-quinazolinones. Another bis-quinazolinone was obtained when two moles of compound 25 was treated with one mole of ethyl tere-phthalate in dimethylformamide under reflux conditions [27, 46].

Figure 26.

Synthesis of Schiff’s bases 51.

4.2.3 Acylation and/or alkylation

Acylation and/or alkylation of 3-amino-4(3H)-quinazolinones 25 using ethyl chloroformate, ethyl chloroacetate, chloro acetylchloride and ethyl acetoacetate in proper solvent afforded 3-(N-acyl/aroylamino)-2-methyl-4(3H)-quinazolinone derivatives 52 [47] ( Figure 27 ).

Figure 27.

Acylation or alkylation of 3-amino-4(3H)-quinazolinones 25.

4.2.4 Reaction with isocyanate and isothiocyanates

Some new urea and thiourea derivatives 53 were synthesized by treatment of 3-amino-4(3H)-quinazolinones 25 with isocyanates and isothiocyanates [28] ( Figure 28 ).

Figure 28.

Synthesis of urea and thiourea derivatives 53.

4.2.5 Reaction with oxazole

Condensation of 3-aminoquinazoline 25 with oxazole derivatives afforded imidazole derivatives 54 [47] ( Figure 29 ).

Figure 29.

Synthesis of imidazole derivatives 54.

4.3 Electrophilic substitution

4.3.1 Nitration

Nitration of 4(3H)-quinazolinone 39 with fuming nitric acid and sulphuric acid afforded 6-nitro-4(3H)-quinazolinone derivative 55 [48] ( Figure 30 ).

Figure 30.

Nitration of 4(3H)-quinazolinone 39.

4.3.2 Chlorination

Heating of 4(3H)-quinazolinones 56 with chlorination agent afforded 4-chloroquinazolines 57 [49]. Chlorination agent was phosphoryl chloride alone or a mixture of phosphorus pentachloride and phosphoryl chloride, other chlorinating agents such as thionyl chloride or phosgene was used for chlorination of quinazolinones ( Figure 31 ).

Figure 31.

Chlorination of 4(3H)-quinazolinone derivatives 56.

4.3.3 Bromination

The use of bromine in acetic acid for direct bromination of 3-amino-2-methylquinazolin-4(3H)-one 25 has been reported for the formation of 6-bromo-3-amino-2-methylquinazolin-4(3H)-ones 58 ( Figure 32 ) [50].

Figure 32.

Synthesis of 6-bromoquinazolinone 58 and 6-iodoquinazolinone 49.

4.3.4 Iodination

Treatment of 3-amino-2-methylquinazolin-4(3H)-one 25 with iodine monochloride in acetic acid afforded the corresponding 6-iodo-3-amino-2-methylquinazolin- 4(3H)-one 49 in high yields [50] ( Figure 32 ).

4.4 Reaction of 4(3H)-quinazolinones with metal ions

3-Amino-4(3H)-quinazolinones 25 possess coordinating sites and they were applied to form complexes 59 and bis-complexes 60 with different metal ions ( Figure 33 ) [51, 52, 53]. Also, considerable attention has been directed to the chemistry of their Schiff’s bases 51 and 61 [27], where the Schiff’s base complexes of 4(3H)-quinazolinones 62-65 were prepared and characterized. The complexes of metal ions with 2-substituted-3-anilino-4(3H) quinazolinone were prepared [54]. Moreover, the complexes of Cu (II), Co (II), Zn (II) and Cd (II) with 2-methyl-3-hydroxy-4(3H)-quinazolinone and 2-methyl-3-pyridinyl-4(3H)-quinazolinone have been prepared [55]. The analytical and spectral data indicate these ligands act as bidentate and the metal complexes are octahedral, tetragonal, square planer and tetrahedral [56].

Figure 33.

Reaction of 4(3H)-quinazolinones 25, 51 and 61 with metal ions.

Thiosemicarbazones can be reacting with metallic cations to give metal complexes. Thiosemicarbazones 66 as the ligands act as chelating agents which were bonding through the sulfur and azomethene nitrogen atoms ( Figure 34 ). So, when metal salts such as CuCl2 or ZnCl2 were treated with the thiosemicarbazone derivatives 66 (0.01 mole) in dioxane the corresponding complexes 67 were obtained in good yield. On the other hand, the corresponding biscomplexes 68 were afforded when a solution of CuCl2 or ZnCl2 (0.01 mole) was added to a stirred solution of thiosemicarbazone derivatives (0.02 mole) in dioxane at reflux temperature [22].

Figure 34.

Preparation of thiosemecarbazone complexes 67 and 68.

4.5 Cycloaddition reaction

Reaction of quinazolinone derivatives 69 with malononitrile gave pyrrolo-quinazolinones 70 [57] ( Figure 35 ). Several new pyrrolo-quinazolinone derivatives were synthesized via a novel rote involving the action of dipolarophiles on the diionic species generated in situ from the reaction of N-chlorosuccinimide with 2-methylquinazolin-4-one and subsequent treatment with triethyl amine [58].

Figure 35.

Synthesis of pyrrolo-quinazolinones 70.

4.6 Action of phosphorous sulphide

Treating of 4(3H)-quinazolinone derivatives 24 with P2S5 or phosphorus decasulfide in pyridine afforded the corresponding 2-methyl-3-aryl-quinazoline-4(3H)-thiones 71 [59] ( Figure 36 ).

Figure 36.

Synthesis of 2-methyl-3-aryl-quinazoline-4(3H)-thiones 71.

Advertisement

5. Biological properties

Quinazoline is the building stone for many naturally occurring alkaloids [60]. Many 4(3H)-quinazolinone derivatives represent an important category among heterocyclic compounds of medicinal interest. Other derivatives of 4(3H)-quinazolinones possess a wide range of biological activities especially on the central nervous system. Moreover, other quinazoline derivatives have been reported for their broad-spectrum biological activities as herein illustrated.

5.1 4(3H)-Quinazolinone derivatives as antitumour

Structure modification of folic acid led to the discovery of a number of antifo-lates as efficient anticancer agents. For example, Raltitrexed has been registered for the treatment of cancer [61]. Many quinazolinone derivatives with side chains have been reported to exhibit significant inhibitory activity against tumor cells [62]. The 2-substituted mercapto-4(3H)-quinazolinone bearing 6-iodo and 2-heteroarylthio is identified as active anticancer agent [63].

5.2 4(3H)-Quinazolinone derivatives as sedative hypnotic agents

The designation of the sedative hypnotic activity of 4(3H)-quinazolinones led to the discovery of methaqualone as nonbarbiturate hypnotic agent. In 1965, methaqualone was introduced as sleeping pills (nonaddictive, nonbarbiturate) under the trade name Quaalude. Due to the abuse of methaqualone, it is banned in most countries [64].

5.3 4(3H)-Quinazolinone derivatives as anticonvulsant agents

The search for new antiepileptic drugs with reduced toxicity and lower side-effects is continuous. 4(3H)-Quinazolinone represents a very good nucleus for preparation of some new sedative/hypnotic and anticonvulsant agents, since such a heterocyclic system possesses the pharmacophoric moiety. From the literature survey, it was found that the 3H-quinazolin-4-one has been reported to possess different pharmacological effects, namely, sedative-hypnotic and anticonvulsant ones [65].

5.4 4(3H)-Quinazolinone derivatives as antimicrobial agents

A large number of quinazolinone derivatives have been synthesized and screened for their antimicrobial activities, and some of them showed their efficacy [66]. Also, quinazolinones metal complexes were synthesized, and their antimicrobial activities were screened. It is observed that the ligands exhibited less fungicidal activities than their complexes. Also the antibacterial activities were increased when quinazolines were complexed with metals.

5.5 4(3H)-Quinazolinone derivatives as anti-inflammatory agents

Thiadiazolyl-3-amino-4(3H)-quinazolinone derivatives was prepared in quantities yields. The products were evaluated for anti-inflammatory properties by std. in vivo and in vitro models, and they exhibited significant protection against carrageenan-induced rat paw oedema [67].

5.6 4(3H)-Quinazolinone derivatives as diuretic agents

Some 4(3H)-quinazolinone derivatives bearing thiazole or 1,3,4-thiadiazole moieties were prepared due to their expected diuretic activity. Some of them showed significant diuretic activity [68].

Advertisement

6. Conclusion

A large number of compounds which contain quinazoline moiety are known in medicinal chemistry as important compounds for their therapeutic value. Recently, there has been an increased interest in the chemistry of 4(3H)-quinazolinone system. Many derivatives of this system showed analgesic, anti-inflammatory, antiulcer, anticonvulsant, antibacterial, antifungal, anticancer and antiproliferative activities. The most common approaches to synthesize 3,2-disubstituted-4(3H)-quinazolinone derivatives involve the following steps: the amidation of 2-aminobenzoic acid derivatives and treatment of amidated anthranilic acid derivatives with acetic anhydride (or acid chloride) to afford the benzoxazinone, followed by their condensation with nitrogen nucleophiles.

References

  1. 1. Abbas SY, El-Bayouki KAM, Basyouni WM. Utilization of isatoic anhydride in the syntheses of various types of quinazoline and quinazolinone derivatives. Synthetic Communications. 2016;46(12):993-1035
  2. 2. Safari J, Gandomi-Ravandi S. Silver decorated multi-walled carbon nanotubes as a heterogeneous catalyst in the sonication of 2-aryl-2,3-dihydroquinazolin-4(1H)-ones. RSC Advances. 2014;4:11654-11660
  3. 3. Kim NY, Cheon C-H. Synthesis of quinazolinones from anthranilamides and aldehydes via metal-free aerobic oxidation in DMSO. Tetrahedron Letters. 2014;55:2340-2344
  4. 4. Cheng R, Tang L, Guo T, Zhang-Negrerie D, Du Y, Zhao K. Oxidant- and metal-free synthesis of 4(3H)-quinazolinones from 2-amino-N-methoxybenzamides and aldehydes via acid-promoted cyclocondensation and elimination. RSC Advances. 2014;4:26434-26438
  5. 5. Rao R, Raghunadh A, Mekala R, Meruva S, Pratap T, Krishna T, et al. Glyoxylic acid in the reaction of isatoic anhydride with amines: A rapid synthesis of 3-(un)substituted quinazolin-4(3H)-ones leading to rutaecarpine and evodiamine. Tetrahedron Letters. 2014;55:6004-6006
  6. 6. Santagati N, Bousquet E, Spadaro A, Ronsisvalle G. 4-Quinazolinones: Synthesis and reduction of prostaglandin E2 production. Il Farmaco. 1999;54:780-784
  7. 7. Jiang JB, Hesson DP, Dusak BA, Dexter DL, Kang GL, Hamel E. Synthesis and biological evaluation of 2-styrylquinazolin-4(3H)-ones, a new class of antimitotic anticancer agents which inhibit tubulin polymerization. Journal of Medicinal Chemistry. 1990;33:1721-1728
  8. 8. Rad-Moghadam K, Mohseni M. An expeditious and solvent-free route to the synthesis of 2-substituted quinazolin-4(3H)-ones under microwave conditions. Journal of Chemical Research. 2003;35:487
  9. 9. Li F, Feng Y, Meng Q, Li W, Li Z, Tao F. An efficient construction of quinazolin-4(3H)-ones under microwave irradiation. Arkivoc. 2007;i:40-50
  10. 10. Baker BR, Almaula PI. Nonclassical antimetabolites. X. A facile synthesis of 4-quinazolone-2-carboxylic acid and the structure of bogert’s ammonium salt. The Journal of Organic Chemistry. 1962;27:4672-4674
  11. 11. Hennequin LF, Boyle FT, Wardleworth JM, Marsham PR, Kimbell R, Juckman AL. Quinazoline antifolates thymidylate synthase inhibitors: Lipophilic analogues with modification to the C2-methyl substituent. Journal of Medicinal Chemistry. 1996;39:695-704
  12. 12. Connolly DJ, Guiry PJ. A facile and versatile route to 2-substituted-4(3H)-quinazolinones and quinazolines. Synlett. 2001;11:1707-1710
  13. 13. Yang RY, Kaplau A. A concise and efficient solid-phase synthesis of 2-amino-4(3H)-quinazolinones. Tetrahedron Letters. 2000;41:7005-7008
  14. 14. Croce PD, Ferracioli R, La Rosa C. Reactivity of 1-Aryl-4-dimethylamino-2-phenyl-1,3-diaza-1,3-butadienes towards Dienophiles, 1,3-Dipoles and Carbanions. Heterocycles. 1997;45:1309-1318
  15. 15. Couture A, Cornet H, Grandclaudon P. An expeditious synthesis of 2-aryl- and 2-alkylquinazolin-4(3H)-ones. Synthesis. 1991;1991:1009-1010
  16. 16. Hess HJ, Cronin TH, Scriabine A. Antihypertensive 2-amino-4(3H)-quinazolinones. Journal of Medicinal Chemistry. 1968;11:130-136
  17. 17. Abdel-Jalil RJ, Volter W, Saeed M. A novel method for the synthesis of 4(3H)-quinazolinones. Tetrahedron Letters. 2004;45:3475-3476
  18. 18. Majo VJ, Perumal PT. Dimerization of substituted 2-aminobenzoic acids under Vilsmeier conditions: A novel route to the synthesis of 4-(3H)-quinazolinones. Tetrahedron Letters. 1996;37:5015-5018
  19. 19. Dai X, Virgil S. Synthesis of 2-heterosubstituted quinazolinone atropisomeric phosphine ligands by direct lithiation of a 2-unsubstituted quinazolinone system. Tetrahedron: Asymmetry. 1999;10:25-29
  20. 20. Khosropour AR, Baltork IM, Ghorbankhani H. Bi(TFA)3-[nbp]FeCl4: A new, efficient and reusable promoter system for the synthesis of 4(3H)-quinazolinone derivatives. Tetrahedron Letters. 2006;47:3561-3564
  21. 21. Narasimhulu MJ, Mahesh KC, Reddy TS, Venkalesewarlu Y. Lanthanum(III) nitrate hexahydrate or p-toluenesulfonic acid catalyzed one-pot synthesis of 4(3H)-quinazolinones under solvent-free conditions. Tetrahedron Letters. 2006;47:4381-4383
  22. 22. El-Bayouki KAM, Aly MM, Mohamed YA, Basyouni WM, Abbas SY. Synthesis and biological activity of some 4(3H)-quinazolinone-2-carboxaldehyde thiosemicarbazone and their metal complexes. European Journal of Medicinal Chemistry. 2010;45:3365-3373
  23. 23. Farag AA, Khalifa EM, Sadik NA, Abbas SY, Al-Sehemi AG, Ammar YA. Synthesis, characterization and evaluation of some novel 4(3H)-quinazolinone derivatives as anti-inflammatory and analgesic agents. Medicinal Chemistry Research. 2013;22:440-452
  24. 24. Abbas SY, El-Bayouki KAM, Basyouni WM, Mostafa EA. New series of 4(3H)-quinazolinone derivatives: Syntheses and evaluation of antitumor and antiviral activities. Medicinal Chemistry Research. 2018;27:571-582
  25. 25. Párkányi CJ, Schmidt DS. Synthesis of 5-chloro-2-methyl-3-(5-methylthiazol-2-yl)-4(3H)-quinazolinone and related compounds with potential biological activity. Journal of Heterocyclic Chemistry. 2000;37:725-729
  26. 26. El-Bayouki KAM, Aly MM, Mohamed YA, Basyouni WM, Abbas SY. Novel 4(3H)-quinazolinone containing biologically active thiazole, pyridinone and chromene of expected antitumor and antifungal activity. European Journal of Chemistry. 2011;2(4):455-462
  27. 27. El-Bayouki KAM, Aly MM, Mohamed YA, Basyouni WM, Abbas SY. Synthesis and biological activities of some 3-(amino or arylidine)-2-pyridinyl-4(3H)-quinazolinone and some of their complexes. Al-Azhar Bulletin of Science. 2010;21:1-20
  28. 28. Ammar YA, Mohamed YA, El-Gaby MSA, Abbas SY. Synthesis of some biologically active 4(3H)-quinazolinones derived from 2,3-pyridine dicarboxylic anhydride. Chemical Sciences Journal. 2011;2011:1-10
  29. 29. Xue S, McKenna J, Shieh W-C, Repic O. A Facile synthesis of C 2,N 3-disubstituted-4-quinazolone. The Journal of Organic Chemistry. 2004;69:6474-6477
  30. 30. Dai X, Wong A, Virgil S. Synthesis and resolution of quinazolinone atropisomeric phosphine ligands. The Journal of Organic Chemistry. 1998;63:2597-2600
  31. 31. Yu Y, Ostresh JM, Houghten RA. A traceless approach for the parallel solid-phase synthesis of 2-(arylamino)quinazolinones. The Journal of Organic Chemistry. 2002;67:5831-5834
  32. 32. Larksarp C, Alper H. Palladium-catalyzed cyclocarbonylation of o-iodoanilines with heterocumulenes: Regioselective preparation of 4(3H)-quinazolinone derivatives. The Journal of Organic Chemistry. 2000;65:2773-2777
  33. 33. Smith K, El-Hiti G, Abbdel-Megeed M, Abdo A. Lithiation of 3-(acylamino)-2-unsubstituted-, 3-(acylamino)-2-ethyl-, and 3-(acylamino)-2-propyl-4(3H)-quinazolinones: Convenient syntheses of more complex quinazolinones. The Journal of Organic Chemistry. 1996;61:647-655
  34. 34. Khatab TK, El-Bayouki KAM, Basyouni WM, El-Basyoni FA, Ali MM, Abbas SY, et al. A novel series of 2,3-dihydroquinazolin-4(1H)-one derivatives: Efficient one-pot synthesis and evaluation of antitumor and antiviral activity. Research Journal of Pharmaceutical, Biological and Chemical Sciences. 2015;6(1):281-291
  35. 35. Ma Y, Ren D, Zhang J, Liu J, Zhao J, Wang L, et al. Synthesis, antibacterial activities evaluation, and docking studies of some 2-substituted-3-(phenylamino)-dihydroquinazolin-4(1H)-ones. Tetrahedron Letters. 2015;56:4076-4079
  36. 36. Weddig A. Beiträge zur kenntniss des o-amidobenzamids, mitgetheilt von a. weddige. Journal für Praktische Chemie. 1887;36:141-154
  37. 37. Culbertson H, Decius JC, Christensen BE. Quinazolines. XIII. A study of the infrared spectra of certain quinazoline derivatives. Journal of the American Chemical Society. 1952;47:4834-4838
  38. 38. Sim Y-L, Omer N, Khan MN, Pratt LM. Ultravioletevisible study on acidebase equilibria of 2-substituted-4(3H)-quinazolinones. Tetrahedron. 2013;69:2524-2533
  39. 39. Brahman D, Sinha B. Synthesis, characterization and antibacterial activities of Zn(II) and Cd(II) complexes of a 3-amino-2-phenylquinazolin-4(3H)-one Schiff base. Journal of the Serbian Chemical Society. 2014;79(12):1505-1513
  40. 40. Jatav V, Mishra P, Kashaw S. Synthesis and CNS depressant activity of some novel 3-[5-substituted 1,3,4-thiadiazole-2-yl]-2-styryl quinazoline-4(3H)-ones. European Journal of Medicinal Chemistry. 2008;43(9):1945
  41. 41. Hassan GS, Georgey HH, Ibrahim NA, Zaki SS. Synthesis of novel substituted quinazoline and quinazolin-4(3H)-one derivatives of expected antitumor activity. Der Pharma Chemica. 2015;7(7):106-119
  42. 42. Sugimoto O, Yamauchi Y, Tanji K-I. Preparation of a useful synthetic precursor, 2-substituted 4(3H)-quinazolinone: Directed lithiation and N3-deprotection of 3-t-butoxycarbonyl-4(3H)- quinazolinone. Heterocycles. 2002;57:323-326
  43. 43. Smith K, Hiti G, Abdel-Mageg MF, Abdo MA. Lithiation of 2-alkyl-3-amino- and 2-alkyl-3-(methylamino)-4(3H)-quinazolinones. The Journal of Organic Chemistry. 1996;61:656-661
  44. 44. Rathman L, Sleevi CM, Krafft ME, Wolfe JF. Functionalization of 2-methyl-3-o-tolyl-4(3H)-quinazolinone and related compounds through carbanion reactions at the 2-methyl group. The Journal of Organic Chemistry. 1980;45:2169-2176
  45. 45. Wolfe JF, Rathman TL, Sleevi MC, Campbell JA, Greenwood TD. Synthesis and anticonvulsant activity of some new 2-substituted 3-aryl-4(3H)-quinazolinones. Journal of Medicinal Chemistry. 1990;33:161-166
  46. 46. Madkour HMF. Reactivity of 4H-3,1-benzoxazin-4-ones towards nitrogen and carbon nucleophilic reagents: Applications to the synthesis of new heterocycles. Arkivoc. 2004;I:36-54
  47. 47. Ibrahim SS, Abdel-Halim AM, Gaber Y, El-Edfawy S, Abdel-Rahman RM. Synthesis and Biological evaluation of some new fused quinazoline derivatives. The Journal of Chemical Research. 1997;1041:154
  48. 48. Kabri Y, Verhaeghe P, Gellis A, Vanelle P. Regioselective Suzuki-Miyaura Reaction: Application to the Microwave-promoted Synthesis of 4,7-Diarylquinazolines. Molecules. 2010;15(5):2949-2961
  49. 49. Takase Y, Saeki T, Watanabe N, Adachi H, Souda S, Saito I, et al. Phosphodiesterase inhibitors. 2. Requirement of 6-substitution of quinazoline derivatives for potent and selective inhibitory activity. Journal of Medicinal Chemistry. 1994;37(13):2106-2111
  50. 50. Mudassar A, Yeshwant B. Synthesis of 6-iodo/bromo- 3-amino-2-methylquinazolin-4(3H)-ones by direct halogenation and their Schiff base derivatives. Arkivoc. 2006;xi:221-226
  51. 51. Reddy KL, Chandraiah AR, Reddy KA, Lingaiah P. Spectral studies of platinum(II) complexes with 2,3-disubstituted quinazolin-(3H)-4-ones. Indian Journal of Chemistry -Section A. 1989;28A:622-626
  52. 52. Prasad KS, Kumar LS, Chandan S, Jayalakshmi B, Revanasiddapp HD. Diorganotin(IV) complexes of biologically potent 4(3H)-quinazolinone derived Schiff bases: Synthesis, spectroscopic characterization, DNA interaction studies and antimicrobial activity. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy. 2011;81:276-282
  53. 53. Reddy KL, Reddy KV, Lingaiah P. Ruthenium(II) complexes with 2-methyl-3-substituted (3H)-quinazolin-4-ones. Polyhydron. 1986;5:1519
  54. 54. Reddy KL, Srihari S, Lingaiah P. Synthesis & characterization of complexes of copper(II), nickel(II), cobalt(II), zinc(II) & cadmium(II) with 2-methyl/phenyl-3-anilinoquinazoline-4-ones. Indian Journal of Chemistry. 1984;23A:172
  55. 55. Reddy KL, Srihari S, Lingaiah P. Synthesis & characterization of complexes of Co(II), Ni(II), Cu(II), Zn(II) & Cd(II) with 2,3-disubstituted quinazolin-(3H)-4-ones. Indian Journal of Chemistry. 1985;24A:318-322
  56. 56. Prabhakar B, Reddy K, Lingaiah P. Synthesis & spectral studies of complexes of Co(II), Ni(II), Cu(II), Zn(II), Ru(II), Pd(II) & Pt(II) with 2,3-disubstituted quinazolin-(3H)-4-ones. Indian Journal of Chemistry -Section A. 1988;27A:217-221
  57. 57. Hishmat OH, Magd El-Din AA, Ismail NA. Synthesis of new substituted pyridines, pyrano[2,3-d]imidazoles and pyrrolo[2,1-b]quinazolines. Organic Preparations and Procedures International. 1992;24:33-37
  58. 58. Ghabrial SS, Zaki MY. Dipolar cycloaddition reactions with quinazolinones: A new synthesis of azoloquinazolinone derivatives. The Journal of Chemical Research. 1997;234:1560
  59. 59. Kubicová L, Kráľová K, Chobot V, Vytlačilová J, Jahodář L, Kaustová J. Synthesis and biological evaluation of quinazoline-4-thiones. Molecules. 2003;8:756-769
  60. 60. Michael JP. Quinoline, quinazoline and acridone alkaloids. Natural Product Reports. 2005;22:627-646
  61. 61. Cunningham D, Zalcberg J, Maroun J, James R, Clarke S, Maughan TS, et al. Efficacy, tolerability and management of raltitrexed (Tomudex™) monotherapy in patients with advanced colorectal cancer: A review of phase II/III trials. European Journal of Cancer. 2002;38:478-486
  62. 62. Cao S-L, Feng Y-P, Jiang Y-Y. Synthesis and in vitro antitumor activity of 4(3H)-quinazolinone derivatives with dithiocarbamate side chains. Bioorganic and Medicinal Chemistry Letters. 2005;15:1915-1917
  63. 63. Khalil AA, Abdel-Hamed SG, El-Subbagh HI. Substituted quinazolines, part 2. Synthesis and in-vitro anticancer evaluation of new 2-substituted mercapto-3H-quinazoline analogs. Archiv der Pharmazie und Berichte der Deutschen Pharmazeutischen Gesellschaft. 2003;2:95-103
  64. 64. Van Zyl EF. A survey of reported synthesis of methaqualone and some positional and structural isomers. Forensic Science International. 2001;122:142-149
  65. 65. El-Helby AA, Abdel-Wahab MHA. Design and synthesis of some new derivatives of 3H-quinazolin-4-one with promising anticonvulsant activity. Acta Pharmaceutica. 2003;53:127-138
  66. 66. Gatadi S, Lakshmi TV, Nanduri S. 4(3H)-Quinazolinone derivatives: Promising antibacterial drug leads. European Journal of Medicinal Chemistry. 2019;170:157-172
  67. 67. Sarma GV, Thomas J, Murugan V, Elango K. Nicotinyl incorporated quinazolinonyl thiadiazoles as possible NSAIDS. Indian Journal of Heterocyclic Chemistry. 1999;9:150-151
  68. 68. Maarouf A, El-Bendary E, Goda FE. Synthesis and evaluation of some novel quinazolinone derivatives as diuretic agents. Archiv der Pharmazie. 2004;337:527-532

Written By

Samir Y. Abbas

Submitted: 26 March 2019 Reviewed: 11 October 2019 Published: 22 January 2020